Story excerpt provided by Technology Networks.
Quest Diagnostics announced it has formed a definitive agreement to acquire Cleveland HeartLab from equity investors, including Cleveland Clinic. Quest intends to establish a national center of excellence in diagnostic information services at Cleveland HeartLab’s specialized laboratory in Cleveland, Ohio, focused on services that aid in assessing risk and treatment protocols for heart disease, the leading cause of death in the United States.
The equity transaction is expected to be completed in the fourth quarter of 2017, subject to customary regulatory reviews. Additional financial terms were not disclosed.
Click here to read the complete article.
Originally published October 19, 2017.